Xponential Fitness, Inc. (XPOF)

Q: What's priced into Xponential Fitness, Inc. (XPOF) stock?

The evidence labels valuation as justified, but the model has low confidence and the shares carry an 18.22% premium to peers. The small expectations gap and optionality driver suggest some room for favorable outcomes is recognized, but the snapshot does not show that a recovery is assumed.

Q: What does the Xponential Fitness, Inc. (XPOF) outlook hinge on?

A favorable shift would require guidance to recover after the recent cut and evidence that the revenue and studio-opening plans are back on track. Sector results are another swing factor, while the strategic review could matter but has not yet produced reported financial outcomes.

NYSEConsumer DiscretionaryLeisureSnapshot 2026-10-23

$4.19-0.24%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Xponential Fitness, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	65.55M
EPS	—	0.14
FY 2026 · Annual
Revenue	$250M–$260M	255.22M
EPS	—	0.23
EBITDA	$91M–$97Mnon-GAAP	—
FY 2027 · Annual
Revenue	—	268.85M
EPS	—	0.492

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Improve cash from operations toward positive territory	Cash flow from operations is improving but still negative.	Broken	Cash from operations remains negative or worsens over next year	Cash from operations: $-4.038M FY2026-Q2; GAAP. Published target: Cash from operations improves from -$21.7M in Q1 2026. Target period is not explicitly aligned with this observation. Source published Aug 7, 2026-4,038,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 recent quarters. Net cash used in operating activities worsened from $21.7 million in Q1 2026 to $25.7 million in Q2 2026, indicating deteriorating cash flow. Management's focus on improving cash from operations has not yet translated into positive cash flow, showing limited progress. Delivery assessment Oct 24, 2026
Stabilize management after recent executive departures	A supporting condition in Xponential Fitness, Inc.'s published investment case. The stated target is No further key executive departures in next 12 months.	Under Pressure	Additional CEO, COO, or President departures occur	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue reaches $260M to $270M in full year 2026	A primary condition in Xponential Fitness, Inc.'s published investment case. The stated target is >= $260M and <= $270M.	Broken	Full year 2026 revenue falls below $260M	Revenue: $2.703M FY2026-Q2; GAAP. Published target: >= $260M and <= $270M. Target period is not explicitly aligned with this observation. Source published Aug 7, 20262,703,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 745efc29-9192-42b7-bced-03a2d60c5c7c. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Revenue declined 13% year-over-year in Q2 2026 to $66.0 million and full year 2026 revenue guidance was revised downward from $260-$270 million to $250-$260 million, representing a 19% decrease at midpoint. Management has consistently emphasized this revenue target but the trajectory shows declining revenue and the company is not delivering growth. Delivery assessment Oct 24, 2026
Open 150 to 170 new studios in 2026	It plans to open 150 to 170 new studios this year.	Intact	Net new studio openings fall below 150 in 2026	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Management guided net new studio openings in 2026 to approximately 150, down from prior guidance of 150 to 170, reflecting a 25% decrease. This priority has been consistently emphasized but the reduced guidance indicates limited growth in studio expansion. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPSUnavailable

$0.77 → Unavailable · observed estimates

FY2027 revenue$0.27B

$0.28B → $0.27B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$0.77	$279,496,210	6 / 8
2026-07-25	$0.77	$279,496,210	6 / 8
2026-07-26	$0.77	$279,496,210	6 / 8
2026-07-27	$0.77	$279,496,210	6 / 8
2026-07-28	$0.77	$279,496,210	6 / 8
2026-07-29	Unavailable	$279,231,381	4 / 6
2026-07-30	$0.77	$279,496,210	6 / 8
2026-07-31	$0.77	$279,496,210	6 / 8
2026-08-01	Unavailable	$279,231,381	4 / 6
2026-08-02	$0.77	$279,496,210	6 / 8
2026-08-03	Unavailable	$279,231,381	4 / 6
2026-08-04	$0.77	$279,496,210	6 / 8
2026-08-05	$0.76	$280,317,100	5 / 7
2026-08-06	Unavailable	$280,153,278	4 / 6
2026-08-08	Unavailable	$275,859,950	4 / 7
2026-08-09	Unavailable	$280,153,278	4 / 6
2026-08-10	Unavailable	$280,153,278	4 / 6
2026-08-12	Unavailable	$271,165,240	4 / 7
2026-08-13	Unavailable	$271,165,240	4 / 7
2026-08-14	Unavailable	$280,153,278	4 / 6
2026-08-15	Unavailable	$280,153,278	4 / 6
2026-08-16	Unavailable	$280,153,278	4 / 6
2026-08-17	Unavailable	$280,153,278	4 / 6
2026-08-18	Unavailable	$280,153,278	4 / 6
2026-08-19	Unavailable	$280,153,278	4 / 6
2026-08-20	Unavailable	$271,222,381	4 / 6
2026-08-21	Unavailable	$271,222,381	4 / 6
2026-08-22	Unavailable	$271,222,381	4 / 6
2026-08-23	Unavailable	$271,222,381	4 / 6
2026-08-24	Unavailable	$271,222,381	4 / 6
2026-08-25	Unavailable	$271,222,381	4 / 6
2026-08-26	Unavailable	$271,222,381	4 / 6
2026-08-27	Unavailable	$271,222,381	4 / 6
2026-08-28	Unavailable	$271,222,381	4 / 6
2026-08-29	Unavailable	$271,222,381	4 / 6
2026-08-30	Unavailable	$271,222,381	4 / 6
2026-08-31	Unavailable	$271,222,381	4 / 6
2026-09-01	Unavailable	$271,222,381	4 / 6
2026-09-02	Unavailable	$271,222,381	4 / 6
2026-09-03	Unavailable	$271,222,381	4 / 6
2026-09-04	Unavailable	$271,222,381	4 / 6
2026-09-05	Unavailable	$271,222,381	4 / 6
2026-09-06	Unavailable	$271,222,381	4 / 6
2026-09-07	Unavailable	$271,222,381	4 / 6
2026-09-08	Unavailable	$271,222,381	4 / 6
2026-09-09	Unavailable	$271,222,381	4 / 6
2026-09-10	Unavailable	$271,222,381	4 / 5
2026-09-11	Unavailable	$271,222,381	4 / 5
2026-09-12	Unavailable	$271,222,381	4 / 5
2026-09-13	Unavailable	$271,222,381	4 / 5
2026-09-14	Unavailable	$271,222,381	4 / 5
2026-09-15	Unavailable	$271,222,381	4 / 5
2026-09-16	Unavailable	$271,222,381	4 / 5
2026-09-17	Unavailable	$268,852,130	4 / 5
2026-09-18	Unavailable	$268,852,130	4 / 5
2026-09-19	Unavailable	$268,852,130	4 / 5
2026-09-20	Unavailable	$268,852,130	4 / 5
2026-09-21	Unavailable	$268,852,130	4 / 5
2026-09-22	Unavailable	$268,852,130	4 / 5
2026-09-23	Unavailable	$268,852,130	4 / 5
2026-09-24	Unavailable	$268,852,130	4 / 5
2026-09-25	Unavailable	$268,852,130	3 / 5
2026-09-26	Unavailable	$268,852,130	3 / 5
2026-09-27	Unavailable	$268,852,130	3 / 5
2026-09-28	Unavailable	$268,852,130	3 / 5
2026-09-29	Unavailable	$268,852,130	3 / 5
2026-09-30	Unavailable	$268,852,130	3 / 5
2026-10-01	Unavailable	$268,852,130	3 / 5
2026-10-02	Unavailable	$268,852,130	3 / 5
2026-10-03	Unavailable	$268,852,130	3 / 5
2026-10-04	Unavailable	$268,852,130	3 / 5
2026-10-05	Unavailable	$268,852,130	3 / 5
2026-10-06	Unavailable	$268,852,130	3 / 5
2026-10-07	Unavailable	$268,852,130	3 / 5
2026-10-08	Unavailable	$268,852,130	3 / 5
2026-10-09	Unavailable	$268,852,130	3 / 5
2026-10-10	Unavailable	$268,852,130	3 / 5
2026-10-11	Unavailable	$268,852,130	3 / 5
2026-10-12	Unavailable	$268,852,130	3 / 5
2026-10-13	Unavailable	$268,852,130	3 / 5
2026-10-14	Unavailable	$268,852,130	3 / 5
2026-10-15	Unavailable	$268,852,130	3 / 5
2026-10-16	Unavailable	$268,852,130	3 / 5
2026-10-17	Unavailable	$268,852,130	3 / 5
2026-10-18	Unavailable	$268,852,130	3 / 5
2026-10-19	Unavailable	$268,852,130	3 / 5
2026-10-20	Unavailable	$268,852,130	3 / 5
2026-10-21	Unavailable	$268,852,130	3 / 5
2026-10-22	Unavailable	$268,852,130	3 / 5
2026-10-23	Unavailable	$268,852,130	3 / 5
2026-10-24	Unavailable	$268,852,130	3 / 5

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	2	9
2026-06-01	2	7
2026-07-01	2	7
2026-08-01	2	7
2026-09-01	1	7
2026-10-01	1	7

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 1 Buy / Strong Buy · 7 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Improve cash from operations toward positive territoryPublished status: Broken
Stabilize management after recent executive departuresPublished status: Under Pressure
Revenue reaches $260M to $270M in full year 2026Published status: Broken
Open 150 to 170 new studios in 2026Direct metric needs a verified mapping

Next proof point

Nov 5, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.0%Typical daily move · historical

Downside history

-59.4%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Xponential Fitness, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a higher-risk growth and recovery case, not a proven durable compounder. The thesis is on watch: revenue and studio-opening goals have been reduced, while the strategic review remains unresolved.

What's priced into Xponential Fitness, Inc.

The evidence labels valuation as justified, but the model has low confidence and the shares carry an 18.22% premium to peers. The small expectations gap and optionality driver suggest some room for favorable outcomes is recognized, but the snapshot does not show that a recovery is assumed.

What the fundamentals likely do

Near term, execution remains uncertain: Q2 2026 revenue fell 13% year over year, and full-year revenue guidance was lowered to $250 million to $260 million. Management also reduced its studio-opening range, while the risk of a next-quarter earnings miss is elevated; the multi-year trajectory depends on whether revenue and expansion stabilize.

What Xponential Fitness, Inc. hinges on

A favorable shift would require guidance to recover after the recent cut and evidence that the revenue and studio-opening plans are back on track. Sector results are another swing factor, while the strategic review could matter but has not yet produced reported financial outcomes.

Bottom line

Over the next 1 to 3 years, XPOF remains a watch-stage recovery thesis with elevated execution risk and limited proof that growth goals are being met. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	65.55M
EPS	—	0.14
FY 2026 · Annual
Revenue	$250M–$260M	255.22M
EPS	—	0.23
EBITDA	$91M–$97Mnon-GAAP	—
FY 2027 · Annual
Revenue	—	268.85M
EPS	—	0.492

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPSUnavailable

$0.77 → Unavailable · observed estimates

FY2027 revenue$0.27B

$0.28B → $0.27B · observed estimates

Exact estimates & source dates

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$0.77	$279,496,210	6 / 8
2026-07-25	$0.77	$279,496,210	6 / 8
2026-07-26	$0.77	$279,496,210	6 / 8
2026-07-27	$0.77	$279,496,210	6 / 8
2026-07-28	$0.77	$279,496,210	6 / 8
2026-07-29	Unavailable	$279,231,381	4 / 6
2026-07-30	$0.77	$279,496,210	6 / 8
2026-07-31	$0.77	$279,496,210	6 / 8
2026-08-01	Unavailable	$279,231,381	4 / 6
2026-08-02	$0.77	$279,496,210	6 / 8
2026-08-03	Unavailable	$279,231,381	4 / 6
2026-08-04	$0.77	$279,496,210	6 / 8
2026-08-05	$0.76	$280,317,100	5 / 7
2026-08-06	Unavailable	$280,153,278	4 / 6
2026-08-08	Unavailable	$275,859,950	4 / 7
2026-08-09	Unavailable	$280,153,278	4 / 6
2026-08-10	Unavailable	$280,153,278	4 / 6
2026-08-12	Unavailable	$271,165,240	4 / 7
2026-08-13	Unavailable	$271,165,240	4 / 7
2026-08-14	Unavailable	$280,153,278	4 / 6
2026-08-15	Unavailable	$280,153,278	4 / 6
2026-08-16	Unavailable	$280,153,278	4 / 6
2026-08-17	Unavailable	$280,153,278	4 / 6
2026-08-18	Unavailable	$280,153,278	4 / 6
2026-08-19	Unavailable	$280,153,278	4 / 6
2026-08-20	Unavailable	$271,222,381	4 / 6
2026-08-21	Unavailable	$271,222,381	4 / 6
2026-08-22	Unavailable	$271,222,381	4 / 6
2026-08-23	Unavailable	$271,222,381	4 / 6
2026-08-24	Unavailable	$271,222,381	4 / 6
2026-08-25	Unavailable	$271,222,381	4 / 6
2026-08-26	Unavailable	$271,222,381	4 / 6
2026-08-27	Unavailable	$271,222,381	4 / 6
2026-08-28	Unavailable	$271,222,381	4 / 6
2026-08-29	Unavailable	$271,222,381	4 / 6
2026-08-30	Unavailable	$271,222,381	4 / 6
2026-08-31	Unavailable	$271,222,381	4 / 6
2026-09-01	Unavailable	$271,222,381	4 / 6
2026-09-02	Unavailable	$271,222,381	4 / 6
2026-09-03	Unavailable	$271,222,381	4 / 6
2026-09-04	Unavailable	$271,222,381	4 / 6
2026-09-05	Unavailable	$271,222,381	4 / 6
2026-09-06	Unavailable	$271,222,381	4 / 6
2026-09-07	Unavailable	$271,222,381	4 / 6
2026-09-08	Unavailable	$271,222,381	4 / 6
2026-09-09	Unavailable	$271,222,381	4 / 6
2026-09-10	Unavailable	$271,222,381	4 / 5
2026-09-11	Unavailable	$271,222,381	4 / 5
2026-09-12	Unavailable	$271,222,381	4 / 5
2026-09-13	Unavailable	$271,222,381	4 / 5
2026-09-14	Unavailable	$271,222,381	4 / 5
2026-09-15	Unavailable	$271,222,381	4 / 5
2026-09-16	Unavailable	$271,222,381	4 / 5
2026-09-17	Unavailable	$268,852,130	4 / 5
2026-09-18	Unavailable	$268,852,130	4 / 5
2026-09-19	Unavailable	$268,852,130	4 / 5
2026-09-20	Unavailable	$268,852,130	4 / 5
2026-09-21	Unavailable	$268,852,130	4 / 5
2026-09-22	Unavailable	$268,852,130	4 / 5
2026-09-23	Unavailable	$268,852,130	4 / 5
2026-09-24	Unavailable	$268,852,130	4 / 5
2026-09-25	Unavailable	$268,852,130	3 / 5
2026-09-26	Unavailable	$268,852,130	3 / 5
2026-09-27	Unavailable	$268,852,130	3 / 5
2026-09-28	Unavailable	$268,852,130	3 / 5
2026-09-29	Unavailable	$268,852,130	3 / 5
2026-09-30	Unavailable	$268,852,130	3 / 5
2026-10-01	Unavailable	$268,852,130	3 / 5
2026-10-02	Unavailable	$268,852,130	3 / 5
2026-10-03	Unavailable	$268,852,130	3 / 5
2026-10-04	Unavailable	$268,852,130	3 / 5
2026-10-05	Unavailable	$268,852,130	3 / 5
2026-10-06	Unavailable	$268,852,130	3 / 5
2026-10-07	Unavailable	$268,852,130	3 / 5
2026-10-08	Unavailable	$268,852,130	3 / 5
2026-10-09	Unavailable	$268,852,130	3 / 5
2026-10-10	Unavailable	$268,852,130	3 / 5
2026-10-11	Unavailable	$268,852,130	3 / 5
2026-10-12	Unavailable	$268,852,130	3 / 5
2026-10-13	Unavailable	$268,852,130	3 / 5
2026-10-14	Unavailable	$268,852,130	3 / 5
2026-10-15	Unavailable	$268,852,130	3 / 5
2026-10-16	Unavailable	$268,852,130	3 / 5
2026-10-17	Unavailable	$268,852,130	3 / 5
2026-10-18	Unavailable	$268,852,130	3 / 5
2026-10-19	Unavailable	$268,852,130	3 / 5
2026-10-20	Unavailable	$268,852,130	3 / 5
2026-10-21	Unavailable	$268,852,130	3 / 5
2026-10-22	Unavailable	$268,852,130	3 / 5
2026-10-23	Unavailable	$268,852,130	3 / 5
2026-10-24	Unavailable	$268,852,130	3 / 5

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings